Eureka Forbes Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Last week saw the newest quarterly earnings release from Eureka Forbes Limited (NSE:EUREKAFORB), an important milestone in the company's journey to build a stronger business. Revenues were ₹7.0b, approximately in line with whatthe analysts expected, although statutory earnings per share (EPS) crushed expectations, coming in at ₹2.93, an impressive 40% ahead of estimates. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
Taking into account the latest results, the consensus forecast from Eureka Forbes' 13 analysts is for revenues of ₹30.8b in 2027. This reflects a meaningful 10% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to leap 27% to ₹11.92. In the lead-up to this report, the analysts had been modelling revenues of ₹30.8b and earnings per share (EPS) of ₹11.99 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
Check out our latest analysis for Eureka Forbes
The analysts reconfirmed their price target of ₹639, showing that the business is executing well and in line with expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Eureka Forbes analyst has a price target of ₹789 per share, while the most pessimistic values it at ₹546. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that Eureka Forbes' rate of growth is expected to accelerate meaningfully, with the forecast 14% annualised revenue growth to the end of 2027 noticeably faster than its historical growth of 10% p.a. over the past three years. Other similar companies in the industry (with analyst coverage) are also forecast to grow their revenue at 15% per year. Eureka Forbes is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Eureka Forbes analysts - going out to 2029, and you can see them free on our platform here.
You can also see our analysis of Eureka Forbes' Board and CEO remuneration and experience, and whether company insiders have been buying stock.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.